Volume 14 Supplement 1

State of the Art 2016: Research and Review from the 9th Congress of the Asian-Pacific Society on Thrombosis and Hemostasis


Publication of this supplement was funded by APSTH 2016. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.

Taipei, Taiwan

6-9 October 2016

Go to conference site.

Edited by Ming-Ching Shen, Shu-Wha Lin, Ching-Ping Tseng and Jiaan-Der Wang.

Previous Page Page 2 of 2 Next Page
  1. Review

    DOACs – advances and limitations in real world

    The group of new oral anticoagulants or NOACs, now termed direct oral anticoagulants or DOACs, with their favourable results from large scale phase III clinical trials, represent a major advancement and expand...

    Lai Heng Lee

    Thrombosis Journal 2016 14(Suppl 1):17

    Published on: 4 October 2016

  2. Review

    MicroRNA in atherothromobosis: is it useful as a disease marker?

    Atherosclerosis is one of the major causes of death. Data from animal experiments suggest that atherosclerosis involves an inflammatory process of the vascular wall under hyperlipidemia. Atherothrombosis can b...

    Satoshi Fujii, Tomonori Sugiura, Yasuaki Dohi and Nobuyuki Ohte

    Thrombosis Journal 2016 14(Suppl 1):21

    Published on: 4 October 2016

  3. Review

    Anti-thrombotic agents derived from snake venom proteins

    Snake venoms affect blood coagulation and platelet function in a complex manner. However, two classes of venom proteins, snaclecs and disintegrins have been shown to specifically target receptors including GPI...

    Tur-Fu Huang, Chun-Chieh Hsu and Yu-Ju Kuo

    Thrombosis Journal 2016 14(Suppl 1):18

    Published on: 4 October 2016

Previous Page Page 2 of 2 Next Page